Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD)

Sergio Rutella; Caterina Giovanna Valentini; Stefano Ceccarelli; Maria Teresa Romano; Letizia P. Brescia; Giuseppe Maria Milano; Franco Locatelli

doi:10.1016/j.transci.2014.04.004

Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD)

Sergio Rutella
, Caterina Giovanna Valentini
, Stefano Ceccarelli
, Maria Teresa Romano
, Letizia P. Brescia
, Giuseppe Maria Milano
, Franco Locatelli

IRCCS Ospedale pediatrico Bambino Gesù - Roma

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

Extracorporeal photopheresis (ECP) is broadly used in adults with cutaneous T-cell lymphoma, acute or chronic graft-versus-host disease (GVHD), rejection of solid organ transplants, and a variety of autoimmune, cell-mediated diseases. The predominant use of ECP in children and adolescents is for treating GVHD. Children pose specific challenges to ECP, due to their unique physiology and to patient's size. Herein, we will focus on current clinical trials with ECP in children with GVHD, with an emphasis on technical and clinical issues that are peculiar to the paediatric setting. (C) 2014 Elsevier Ltd. All rights reserved.

Lingua originale	Inglese
pagine (da-a)	340-348
Numero di pagine	9
Rivista	Transfusion and Apheresis Science
Volume	50
DOI	https://doi.org/10.1016/j.transci.2014.04.004
Stato di pubblicazione	Pubblicato - 2014

Keywords

Childhood leukemia
Graft-versus-host disease
Stem cell transplantation
Solid organ transplantation
Photopheresis

Accesso al documento

10.1016/j.transci.2014.04.004

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{c29a3e0fda82467ba7368d89c752a149,

title = "Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD)",

abstract = "Extracorporeal photopheresis (ECP) is broadly used in adults with cutaneous T-cell lymphoma, acute or chronic graft-versus-host disease (GVHD), rejection of solid organ transplants, and a variety of autoimmune, cell-mediated diseases. The predominant use of ECP in children and adolescents is for treating GVHD. Children pose specific challenges to ECP, due to their unique physiology and to patient's size. Herein, we will focus on current clinical trials with ECP in children with GVHD, with an emphasis on technical and clinical issues that are peculiar to the paediatric setting. (C) 2014 Elsevier Ltd. All rights reserved.",

keywords = "Childhood leukemia, Graft-versus-host disease, Stem cell transplantation, Solid organ transplantation, Photopheresis, Childhood leukemia, Graft-versus-host disease, Stem cell transplantation, Solid organ transplantation, Photopheresis",

author = "Sergio Rutella and Valentini, \{Caterina Giovanna\} and Stefano Ceccarelli and Romano, \{Maria Teresa\} and Brescia, \{Letizia P.\} and Milano, \{Giuseppe Maria\} and Franco Locatelli",

year = "2014",

doi = "10.1016/j.transci.2014.04.004",

language = "English",

volume = "50",

pages = "340--348",

journal = "Transfusion and Apheresis Science",

issn = "1473-0502",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD)

AU - Rutella, Sergio

AU - Valentini, Caterina Giovanna

AU - Ceccarelli, Stefano

AU - Romano, Maria Teresa

AU - Brescia, Letizia P.

AU - Milano, Giuseppe Maria

AU - Locatelli, Franco

PY - 2014

Y1 - 2014

N2 - Extracorporeal photopheresis (ECP) is broadly used in adults with cutaneous T-cell lymphoma, acute or chronic graft-versus-host disease (GVHD), rejection of solid organ transplants, and a variety of autoimmune, cell-mediated diseases. The predominant use of ECP in children and adolescents is for treating GVHD. Children pose specific challenges to ECP, due to their unique physiology and to patient's size. Herein, we will focus on current clinical trials with ECP in children with GVHD, with an emphasis on technical and clinical issues that are peculiar to the paediatric setting. (C) 2014 Elsevier Ltd. All rights reserved.

AB - Extracorporeal photopheresis (ECP) is broadly used in adults with cutaneous T-cell lymphoma, acute or chronic graft-versus-host disease (GVHD), rejection of solid organ transplants, and a variety of autoimmune, cell-mediated diseases. The predominant use of ECP in children and adolescents is for treating GVHD. Children pose specific challenges to ECP, due to their unique physiology and to patient's size. Herein, we will focus on current clinical trials with ECP in children with GVHD, with an emphasis on technical and clinical issues that are peculiar to the paediatric setting. (C) 2014 Elsevier Ltd. All rights reserved.

KW - Childhood leukemia

KW - Graft-versus-host disease

KW - Stem cell transplantation

KW - Solid organ transplantation

KW - Photopheresis

KW - Childhood leukemia

KW - Graft-versus-host disease

KW - Stem cell transplantation

KW - Solid organ transplantation

KW - Photopheresis

UR - http://hdl.handle.net/10807/242598

U2 - 10.1016/j.transci.2014.04.004

DO - 10.1016/j.transci.2014.04.004

M3 - Article

SN - 1473-0502

VL - 50

SP - 340

EP - 348

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

ER -

Extracorporeal photopheresis for paediatric patients experiencing graft-versus-host disease (GVHD)

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo